Skip to main content
. 2025 Jan 30;18:557–566. doi: 10.2147/IDR.S488617

Table 3.

Characteristics of Gender, Hospitalization, Area of Lymph Node Involvement, Symptoms and Disease Course According to Groups

Individuals (n:317)
Features TB LAP n (%) Other Diagnosesn (%) Malignancy n (%) Total n (%)
Gender
Male 92 (49.5) 25 (40.3) 31 (44.9) 148 (46.7)
Female 94 (50.5) 37 (59.7) 38 (55.1) 169 (53.3)
p > 0.05 *
Hospitalization
Yes 38 (20.4) 9 (14.5) 36 (52.2) 83 (26.2)
No 148 (79.6) 53 (85.5) 33 (47.8) 234 (73.8)
p < 0.05
LAP region
Cervical
Yes 123 (66.1) 43 (69.4) 49 (71.0) 215 (67.8)
No 63 (33.9) 19 (30.6) 20 (29.0) 102 (32.2)
p > 0.05
Supraclavicular
Yes 28 (15.1) 5 (8.1) 6 (8.7) 39 (12.3)
No 158 (84.9) 57 (91.9) 63 (91.3) 278 (87.7)
p > 0.05
Submandibular
Yes 22 (11.8) 6 (9.7) 3 (4.3) 31 (9.8)
No 164 (88.2) 56 (90.3) 66 (95.7) 286 (90.2)
p > 0.05
Symptoms
LAP swelling
Yes 154 (82.8) 46 (74.2) 51 (73.9) 251 (79.2)
No 32 (17.2) 16 (25.8) 18 (26.1) 66 (20.8)
p < 0.05
Fever
Yes 69 (37.1) 27 (43.5) 35 (50.7) 131 (41.3)
No 117 (62.9) 35 (56.5) 34 (49.3) 186 (58.7)
p < 0.05
Weight loss
Yes 26 (14.0) 1 (1.6) 21 (30.4) 48 (15.1)
No 160 (86.0) 61 (98.4) 48 (69.6) 269 (84.9)
p < 0.05
Disease Course
Recovery 175 (94.1) 60 (96.8) 14 (20.3) 249 (78.5)
Complications, Relaps, Death, Unknown 11 (5.9) 2 (3.2) 55 (79.7) 68 (21.5)
p < 0.05

Note: *Pearson’s chi-square test.